Brief: Windtree Therapeutics Reports First Quarter 2023 Financial Results And Provides Key Business Updates
15/05/2023 22:45
Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES KEY BUSINESS UPDATES
* WINDTREE THERAPEUTICS INC - QTRLY LOSS PER SHARE $4.76
* WINDTREE THERAPEUTICS INC - AS OF MARCH 31, 2023, CO
REPORTED
CASH & CASH EQUIVALENTS OF $4.2 MILLION
* WINDTREE-CASH,CASH EQUIVALENTS WITH $10.8 MILLION OF
PROCEEDS
FROM APRIL 2023 UNDERWRITTEN PUBLIC OFFERING,TO FUND BUSINESS
OPERATIONS THROUGH Q1 OF 2024
Source text for Eikon: ID:nGNX353JPX
Further company coverage: WINT.O
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study